✉news HealthMedicine first seen 11 h ago, last 11 h ago, peak #23
Viatris to Acquire Pacira BioSciences in Non-Opioid Pain Push
Original: Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
Viatris has agreed to acquire Pacira BioSciences, the maker of the non-opioid pain medication Exparel. The deal is billed as a step forward in Viatris's strategy to expand its innovative medicines portfolio and position the company as a leader in non-opioid pain therapies. Financial terms and expected closing timelines were not detailed in the announcement, which was released through the company's newsroom.
Why now: A major pharmaceutical acquisition directly relevant to the ongoing debate over opioid alternatives and pain treatment.
ViatrisPacira BioSciencesExparel
Evidence
- Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies · Viatris Newsroom
API: https://socialmediatrends-api.osmike.com/v1/trends/1480200